Hemangioblastoma of the Central Nervous System: A Case Series of Patients Surgically Treated at
Iranian Journal of Child Neurology,
Vol. 13 No. 2 (2019),
4 March 2019
,
Page 163-169
https://doi.org/10.22037/ijcn.v13i2.16714
Abstract
Objective: Hemangioblastoma refers to a benign vascular neoplasm that comprises stromal and capillary cells. Based on the classification of nervous system tumors proposed by the World Health Organization, hemangioblastomas are classified as Grade I meningeal tumors of uncertain origin. These tumors are found almost exclusively in the central nervous system (CNS) and account for 0.9 to 2.1% of all primary CNS tumors.
Methods: In this descriptive retrospective study, the archives of pathology reports were reviewed in the department of pathology of Shohadaye Tajrish Hospital and patients with definite diagnosis of hemangioblastoma made through histpopathological examinations during 2004-2014 were identified. Age, gender and the location of tumor were extracted from the medical records and entered into SPSS statistical software v.22 for analysis.
Results: A total of 30 patients including 16 males (53.3%) and 14 females (46.7%) were identified. The mean age of the patients was calculated to be 41.2±13.47 years, ranging from 19 to 62 years old. The majority of lesions had been found in the cerebellum of the patients (93.3%); only one had occurred in the cerebrum (3.3%) and another in the fourth ventricle (3.3%).
Conclusion: Cerebellum is the most commonly affected location in patients with CNS hemangioblastomas, and a male preponderance is observed in these cases.
- Hemangioblastoma
- Central nervous system
- Location
- Age
- Gender
How to Cite
References
Cushing H, Bailey P. Tumors arising from the blood-vessels of the brain: angiomatous malformations and hemangioblastomas: CC Thomas; 1928.
Rubinstein LJ. Atlas of tumor pathology: tumors of the central nervous system. Government Printing Office; 1990.
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta neuropathologica. 2007;114(2):97-109.
Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 2001;48(1):55-63.
Neumann H, Bender B. Genotype–phenotype correlations in von Hippel–Lindau. Journal of internal medicine. 1998;243:541-5.
Pan J, Sussman E, Tayag A, Thompson P, Chang SD. Central Nervous System Hemangioblastomas: Part I—Incidence. Contemporary Neurosurgery. 2015;37(25):1-5.
Burger PC, Scheithauer BW. Tumors of the Central Nervous System, Atlas of Tumor Pathology. The American Journal of Surgical Pathology. 1995;19(10):1220.
Boughey A, Fletcher N, Harding A. Central nervous system haemangioblastoma: a clinical and genetic study of 52 cases. Journal of Neurology, Neurosurgery & Psychiatry. 1990;53(8):644-8.
Böhling T, Plate K, Haltia M, Alitalo K, Neumann HP. Von Hippel-Lindau disease and capillary haemangioblastoma. Pathology. 2007.
Adegbite AB, Rozdilsky B, Varughese G. Supratentorial capillary hemangioblastoma presenting with fatal spontaneous intracerebral hemorrhage. Neurosurgery. 1983;12(3):327-30.
Goto T, Nishi T, Kunitoku N, Yamamoto K, Kitamura I, Takeshima H, et al. Suprasellar hemangioblastoma in a patient with von Hippel-Lindau disease confirmed by germline mutation study: case report and review of the literature. Surgical neurology. 2001;56(1):22-6.
Peker S, Kurtkaya-Yapıcıer Ö, Sun I, Sav A, Pamir MN. Suprasellar haemangioblastoma. Report of two cases and review of the literature. Journal of clinical neuroscience. 2005;12(1):85-9.
Kachhara R, Nair S, Radhakrishnan V. Sellar-sphenoid sinus hemangioblastoma: case report. Surgical neurology. 1998;50(5):461-4.
Kerr DJ, Scheithauer BW, Miller GM, Ebersold MJ, McPhee TJ. Hemangioblastoma of the optic nerve: case report. Neurosurgery. 1995;36(3):573-81.
Higashida T, Sakata K, Kanno H, Kawasaki T, Tanabe Y, Yamamoto I. Hemangioblastoma of the optic nerve-Case report. Neurologia medico-chirurgica. 2007;47(5):215-8.
Loftus CM, Marquardt MD, Stein BM. Hemangioblastoma of the third ventricle. Neurosurgery. 1984;15(1):67-72.
Isaka T, Horibe K, Nakatani S, Maruno M, Yoshimine T. Hemangioblastoma of the third ventricle. Neurosurgical review. 1999;22(2-3):140-4.
Giannini C, Scheithauer B, Hellbusch LC, Rasmussen A, Fox M, McCormick S, et al. Peripheral nerve hemangioblastoma. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 1998;11(10):999-1004.
Brodkey JA, Buchignani JA, O'Brien TF. Hemangioblastoma of the radial nerve: case report. Neurosurgery. 1995;36(1):198-201.
Patton KT, Satcher RL, Laskin WB. Capillary hemangioblastoma of soft tissue: report of a case and review of the literature. Human pathology. 2005;36(10):1135-9.
Choyke PL, Glenn GM, Walther M, Patronas NJ, Linehan WM, Zbar B. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology. 1995;194(3):629-42.
Hes F, Van Der Luijt R, Lips C. Clinical management of von Hippel–Lindau (VHL) disease. The Netherlands journal of medicine. 2001;59(5):225-34.
Richard S, David P, Marsot-Dupuch K, Giraud S, Béroud C, Resche F. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease. Neurosurgical review. 2000;23(1):1-22.
Wanebo JE, Lonser RR, Glenn GM, Oldfield EH. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. Journal of neurosurgery. 2003;98(1):82-94.
SPSS I. IBM SPSS statistics 22. Algorithms Chicago: IBM SPSS Inc. 2013.
Chawhan SM, Dani AA, Meshram SA, Narkhede SM, Randale AA, Kumbhalkar D. Central nervous system hemangioblastomas: Epidemiology, pathology and clinical spectrum in a tertiary care centre. Astrocyte. 2014;1(3):186.
Catapano D, Muscarella LA, Guarnieri V, Zelante L, D’Angelo VA, D’Agruma L. Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management. Neurosurgery. 2005;56(6):1215-21.
Rosai J. Rosai and Ackerman's Surgical Pathology: Elsevier Health Sciences; 2011.
C. Iplikcioglu VY, U. Trakya, A. Supratentorial haemangioblastoma: appearances on MR imaging. British journal of neurosurgery. 1997;11(6):576-8.
Wizigmann-Voos S, Plate K. Pathology, genetics and cell biology of hemangioblastomas. 1996.
Hoang MP, Amirkhan RH. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma. The American journal of surgical pathology. 2003;27(8):1152-6.
Jurco S, Nadji M, Harvey DG, Parker JC, Font RL, Morales AR. Hemangioblastomas: histogenesis of the stromal cell studied by immunocytochemistry. Human pathology. 1982;13(1):13-8.
Smalley SR, Schomberg PJ, Earle JD, Laws ER, Scheithauer BW, O'Fallon JR. Radiotherapeutic considerations in the treatment of hemangioblastomas of the central nervous system. International Journal of Radiation Oncology* Biology* Physics. 1990;18(5):1165-71.
Suzanne M, Horowitz SA. Hemangioblastomas: clinical and histopathological factors correlated with recurrence. Neurosurgery. 1989;25(5):695-8.
- Abstract Viewed: 216 times